![](/img/cover-not-exists.png)
Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]
Dale Rublee,Steven M Opal,Wolfgang Schramm,Heinz-Otto Keinecke…Volume:
6
Language:
english
Journal:
Critical Care
DOI:
10.1186/cc1529
Date:
August, 2002
File:
PDF, 93 KB
english, 2002